companydata.dkCLINIGMA ApS: Financial statements 2023
CVR: 39350580
CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,233,952 and a net result of DKK 2,346,088 compared with DKK 95,651 the year before. That is an increase of 114% compared with the year before. Equity amounted to DKK -1,233,814. The company had 6 employees in the financial year.
- Gross Profit
- 6,233,952 kr.
- Profit/Loss
- 2,346,088 kr.
- Equity
- -1,233,814 kr.
- Total Assets
- 5,190,854 kr.
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.2 mio. | 2.3 mio. | -1.2 mio. | 6 |
| 2022 | - | 2.9 mio. | 96 t. | -3.6 mio. | 8 |
| 2021 | - | -60 t. | -9.7 mio. | -6.7 mio. | 8 |
| 2020 | - | 5.3 mio. | 2.8 mio. | 2.9 mio. | 4 |
| 2019 | 1.1 mio. | 349 t. | 899 | 562 t. | 2 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CLINIGMA ApS has published its annual report for 2022. Gross profit came to DKK 2,912,882, and the net result was DKK 95,651.
About CLINIGMA ApS
CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity amounted to DKK 69.